↑ Rising
Business
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
5sources
6articles
3velocity
+20%since first seen
just nowfirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (6)
- Celcuity shares fall as launch delay eclipses US approval for breast cancer drug Reuters · 5h ago
- Celcuity’s breast cancer drug approved, its first STAT · 5h ago
- FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer OncLive · 5h ago
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma Fierce Pharma · 5h ago
- US FDA approves Celcuity's breast cancer drug Reuters · 5h ago
- Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits Investor's Business Daily · 5h ago
Related trends
▲ Peaking
Business
Mystery Freedom Fuel stations that sold discounted gasoline tied to NFL coach and commodities trader
▲ Peaking
Business
The hottest AI models in Silicon Valley face a powerful source of competition
▲ Peaking
Business
Fed Chairman Kevin Warsh pushes past Democrats' criticism as they question Trump ties, new task forces
▲ Peaking
Business
Conagra Stock Falls as Guidance Disappoints and the Company Reduces Dividend
▲ Peaking
Business
Fed chair Warsh sidesteps Senate questions on inflation, AI, contact with Trump
▲ Peaking
Business